Lyon: MGM China (02282) rated as "outperform the market" with a target price of HK$11.9.
Lyon believes that MGM has a strong balance sheet and strong ability to generate regular cash flows.
Lyon released a research report stating that MGM CHINA (02282) has been rated as "outperform the market", believing that MGM has a solid balance sheet and strong ability to generate recurring cash flow. The target price is 11.9 Hong Kong dollars.
The report also mentioned that MGM CHINA's property EBITDA in the fourth quarter of last year increased by 7% to 2.126 billion yuan, exceeding market and the bank's expectations by about 4% to 5%. The market share of gaming revenue remained stable at 15.5%, and the EBITDA profit margin slightly decreased by 0.5 percentage points to 26.8%.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


